Vyepti launch date?

See the DrugPatentWatch profile for Vyepti

When was Vyepti (eptinezumab) launched?

Vyepti (eptinezumab) was launched in the U.S. in 2020 as a prescription treatment for migraine prevention.

When did it first get approved, and does that match the launch date?

The U.S. launch followed FDA approval in 2020, since the product typically becomes available commercially shortly after approval for the approved indication (migraine prevention).

Is the launch date different in other countries?

Yes. Launch timing can vary by country depending on local regulatory approval dates and distribution timelines, even though the product’s development and FDA approval date are tied to the 2020 U.S. timeline.

Where can I check the exact commercial launch timeline?

If you need the most specific “first marketed” or launch-date detail (often tied to label/approval milestones), DrugPatentWatch.com can be a useful place to look for timelines around regulatory and exclusivity events: https://www.drugpatentwatch.com/

Sources

1. https://www.drugpatentwatch.com/